Amoeba (PAR: ALMIB)

Last close As at 21/02/2025

EUR0.90

−0.01 (−0.99%)

Market capitalisation

EUR46m

Amoéba is a greentech based in France, which aims to become a major player in treating microbiological risk in the crop protection and cosmetic sectors. Based on the natural properties of a unique, exclusively patented microorganism, its biological solutions offer a viable alternative to the chemical products widely used in the industry today.

Latest Insights

View More

Industrials | Outlook

Amoeba — Focused on high-value opportunities

Industrials | Update

Amoeba — Biocontrol plant paves path to commercialisation

Industrials | Update

Amoeba — Scaling up for commercialisation

Industrials | Update

Amoeba — Building on an exceptional year

Sector

Industrials

Equity Analyst

Michael McNamara

Analyst, Industrials

Key Management

  • Benoit Villers

    Chairman

  • Jean-Francois Doucet

    CEO

Research

Update

Industrials

Amoeba — Building on an exceptional year

edison tv

Industrials

Amoeba – executive interview

Initiation

Industrials

Amoeba — Fighting pathogens, respecting nature

Thematics

thematic

Industrials

Climate: Creating multi-trillion investment opportunities

thematic

Energy & Resources

Renewable energy developers – Creating value for investors

thematic

Industrials

The art of measurement – Challenges in metrology

thematic

Industrials

Deutsches Eigenkapitalforum (EKF) 2023 industrials

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free